Literature DB >> 12913940

Ankylosing spondylitis in Shantou, China: 15 years' clinical experience.

Qing Yu Zeng1.   

Abstract

OBJECTIVE: To study the clinical features of ankylosing spondylitis (AS) in Shantou, China, and assess the therapeutic effect of slow acting antirheumatic drugs (SAARD).
METHODS: Clinical and laboratory data as well as the results of SAARD treatment were analyzed in 370 consecutive cases (46 female) seen in the period 1983-97. All patients met the modified New York criteria for AS. HLA-B27 was present in 83 of 89 (93.3%) patients tested.
RESULTS: Insidious onset was seen in 94.3% of the cases studied: 33.5% with disease onset prior to age 20 years, 53.5% between ages 20-30 years, and 98.1% of all under age 40. Low back pain/discomfort, peripheral arthritis, positive "4" test, and tenderness over the sacroiliac joints/lumbar spine were the most frequent symptoms and signs. With some exceptions, the extent of sacroiliitis and involvement of the hip and spine were closely related to disease duration. Average disease duration was shorter among patients diagnosed after 1989 than before. A total of 107 cases have been followed for more than 3 years, of which 57 patients persisted with SAARD treatment for more than 3 years. Forty-four of the 57 cases (11.9% of the total of 370 cases) resulted in a good prognosis.
CONCLUSION: Early diagnosis of AS in Shantou, China, improved in the 1990s. SAARD were effective in the treatment of AS at least in a small portion of the patients. Patient compliance and longterm treatment were essential to obtain a better outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12913940

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Clinical and radiographic features of adult-onset ankylosing spondylitis in Korean patients: comparisons between males and females.

Authors:  Young-Ok Jung; Inje Kim; Suho Kim; Chang-Hee Suh; Han Jung Park; Won Park; Seoung Ryul Kwon; Jae Cheon Jeong; Yun Jong Lee; Hee Jung Ryu; Young Bae Park; Jisoo Lee; You-Hyun Lee; Young Il Seo; Won Tae Chung; Seung-Jae Hong; Yeon-Sik Hong; Han Joo Baek; Hyo Jin Choi; Hyo-Jong Kang; Chan-Hee Lee; Sang-Hyon Kim; Hyun Ah Kim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

Review 2.  Ankylosing spondylitis: Chinese perspective, clinical phenotypes, and associated extra-articular systemic features.

Authors:  Huei-Huang Ho; Ji-Yih Chen
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

3.  Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China.

Authors:  Yuqing Song; Chen Wang; Hong Chen
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

4.  Gender differences in Iranian patients with ankylosing spondylitis.

Authors:  Abtin Shahlaee; Mahdi Mahmoudi; Mohammad Hossein Nicknam; Elham Farhadi; Sasan Fallahi; Ahmad Reza Jamshidi
Journal:  Clin Rheumatol       Date:  2013-11-28       Impact factor: 2.980

5.  Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.

Authors:  Zhi-duo Hou; Zheng-yu Xiao; Yao Gong; Yu-ping Zhang; Qing Yu Zeng
Journal:  BMC Pharmacol Toxicol       Date:  2014-11-21       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.